Miao-Miao Horng
Pfizer (United States)(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, Click Chemistry and Applications, HIV Research and Treatment, Chemical Synthesis and Analysis, Multicomponent Synthesis of Heterocycles
Most-Cited Works
- → Tipranavir (PNU-140690): A Potent, Orally Bioavailable Nonpeptidic HIV Protease Inhibitor of the 5,6-Dihydro-4-hydroxy-2-pyrone Sulfonamide Class(1998)295 cited
- → Structure-Based Design of HIV Protease Inhibitors: Sulfonamide-Containing 5,6-Dihydro-4-hydroxy-2-pyrones as Non-Peptidic Inhibitors(1996)96 cited
- → Allosteric inhibition of Staphylococcus aureus d -alanine: d -alanine ligase revealed by crystallographic studies(2006)90 cited
- → Structure-Based Design of Novel HIV Protease Inhibitors: Sulfonamide-Containing 4-Hydroxycoumarins and 4-Hydroxy-2-pyrones as Potent Non-Peptidic Inhibitors(1996)88 cited
- → Structure-Based Design of HIV Protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as Effective, Nonpeptidic Inhibitors(1996)86 cited
- → Structure-Based Design of Nonpeptidic HIV Protease Inhibitors: The Sulfonamide-Substituted Cyclooctylpyranones(1997)85 cited
- → Cycloalkylpyranones and Cycloalkyldihydropyrones as HIV Protease Inhibitors: Exploring the Impact of Ring Size on Structure−Activity Relationships(1996)46 cited
- → Structure-Based Design of Nonpeptidic HIV Protease Inhibitors from a Cyclooctylpyranone Lead Structure(1995)26 cited
- → ChemInform Abstract: Structure‐Based Design of Nonpeptidic HIV Protease Inhibitors from a Cyclooctylpyranone Lead Structure.(1996)3 cited
- → ChemInform Abstract: Structure‐Based Design of Novel HIV Protease Inhibitors: Carboxamide‐ Containing 4‐Hydroxycoumarins and 4‐Hydroxy‐2‐pyrones as Potent Nonpeptidic Inhibitors.(1995)3 cited